Log In
BCIQ
Print this Print this
 

CEA CAR-T

  Manage Alerts
Collapse Summary General Information
Company Sorrento Therapeutics Inc.
DescriptionChimeric antigen receptor (CAR) T cells targeting carcinoembryonic antigen (CEA)
Molecular Target Carcinoembryonic antigen (CEA)
Mechanism of Action 
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPhase I
Standard IndicationLiver cancer
Indication DetailsTreat metastatic liver cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today